Charles Sako is 41 and lives with his partner and three-year old daughter in Kibera, a deprived area of the Kenyan capital, Nairobi. Charles is HIV positive and is being treated at an MSF clinic in Kibera. Photograph by Sven Torfinn
Report |

Untangling the Web of Antiretroviral Price Reductions 14th Edition

Photograph by Sven Torfinn

The latest edition of Untangling the Web of Antiretroviral Price Reductions (UTW) released at the IAS 2011 in Rome demonstrates a growing and deadly divide in antiretroviral (ARV) prices offered to the poorest countries versus lower and middle-income countries that are still grappling with the scale-up of life-saving HIV treatment. UTW includes information on the evolution in price for each ARV over time, charting the difference between the originator price and the lowest price available from generic producers for developing countries.

UTW also highlights access issues for each drug, outlining patent restrictions, pricing differentials (tiered prices) for middle-income countries and the status of paediatric formulations. The 14th edition of UTW additionally covers issues that have emerged in access to ARV and the associated problems with development of paediatric formulations and scale-up using newer drugs.

Additional publications in the Untangling the Web report series are available here.

Learn more about MSF’s work to improve access to lifesaving HIV treatment.